Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis Interventions: Drug: Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo; Drug: Ketotifen fumarate ophthalmic solution 0.035%; Drug: Brimonidine tartrate ophthalmic solution 0.025%; Drug: Vehicle ophthalmic solution Sponsor: Bausch & Lomb Incorporated Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials